Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 84 points (-0.5%) at 15,367 as of Wednesday, Aug. 14, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,073 issues advancing vs. 1,847 declining with 114 unchanged. The Health Services industry currently is unchanged today versus the S&P 500, which is down 0.3%. Top gainers within the industry include Alere ( ALR), up 2.6%, Medtronic ( MDT), up 0.7% and Fresenius Medical Care AG & Co. KGaA ( FMS), up 0.5%. On the negative front, top decliners within the industry include Mindray Medical International ( MR), down 2.0%, Agilent Technologies ( A), down 0.9% and Aetna ( AET), down 0.7%. TheStreet would like to highlight 5 stocks pushing the industry higher today: 5. Laboratory Corporation of America Holdings ( LH) is one of the companies pushing the Health Services industry higher today. As of noon trading, Laboratory Corporation of America Holdings is up $0.80 (0.8%) to $99.00 on average volume. Thus far, 315,718 shares of Laboratory Corporation of America Holdings exchanged hands as compared to its average daily volume of 739,900 shares. The stock has ranged in price between $98.01-$99.06 after having opened the day at $98.25 as compared to the previous trading day's close of $98.20. Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. Laboratory Corporation of America Holdings has a market cap of $8.8 billion and is part of the health care sector. Shares are up 13.4% year to date as of the close of trading on Tuesday. Currently there is 1 analyst that rates Laboratory Corporation of America Holdings a buy, 2 analysts rate it a sell, and 11 rate it a hold. TheStreet Ratings rates Laboratory Corporation of America Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in stock price during the past year, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Laboratory Corporation of America Holdings Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.